Labs / ADME, DMPK & toxicology
BIMINI
Leiden, Netherlands · biminibiotech.nl
BIMINI Biotech is a preclinical-stage biotechnology company based in Leiden, the Netherlands. It develops first-in-class small molecule therapeutics by modulating WASp for oncology and autoimmune disease, including acute myeloid leukemia and rheumatoid arthritis.
They take quote requests by email.
What they offer
WASp activation programme
Develops small molecules that increase WASp activity in selected cancers, including hematologic cancer programmes.
WASp inhibition programme
Develops small molecules that reduce WASp function in autoimmune disease by increasing WASp degradation.
Hit-to-lead and lead optimisation
Advances discovered compounds through potency and pharmacokinetic optimisation while maintaining activity.
Preclinical development
Generates in vitro and in vivo proof-of-concept data to support therapeutic programmes.
Partnering and research collaboration
Engages with academic, clinical, and industry partners for research collaborations and partnering discussions.
What they work on
- Modalities
- Small molecule
- Species and models
- hematologic cancer models, leukemia models, lymphoma models, collagen-induced arthritis model
- Assays and studies
- phenotypic screen, target identification, kinase profiling, target engagement, in vitro assays, in vivo proof of concept
- Instruments and platforms
- AI, cheminformatics
- Therapeutic areas
- oncology, autoimmune disease, acute myeloid leukemia, rheumatoid arthritis
- Sites
- Leiden, The Netherlands
- Team
- 4+ team members
- Serves
- worldwide
- Address
- Galileiweg 8 2333 BD Leiden The Netherlands
- Founded
- 2019
Public records
- Ownership
- BIMINI GROUP LTD · VG GLEIF
Similar labs. Aurigene Pharmaceutical Services, EyeCRO, MedChem Partners, Medibiofarma
Found in a contract services directory. Listing built from biminibiotech.nl. Work here? Claim this listing.